In Brief: Aastrom Biosciences
This article was originally published in The Gray Sheet
Executive Summary
Aastrom Biosciences: Ann Arbor, Michigan-based firm gains approval of an investigational device exemption to begin trials on its first product, the Aastrom cell production system (CPS). The system is designed to produce cells for blood and immune system recovery after chemotherapy involving bone marrow transplantation ("The Gray Sheet" Nov. 15, 1994, p. 3). The Phase I trial will involve up to ten breast cancer patients at the M.D. Anderson Cancer Center in Houston, Texas. The firm also is developing Gene Loader technology for delivery of genes into human cells and tissue...